{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T16:02:13Z","timestamp":1720627333069},"reference-count":13,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1370,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1742-1241.2011.02835.x","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T18:02:36Z","timestamp":1323972156000},"page":"1-3","source":"Crossref","is-referenced-by-count":0,"special_numbering":"supplement s174","title":["Quality initiatives and models of care in patients with pulmonary arterial hypertension: The time has come!"],"prefix":"10.1155","volume":"65","author":[{"given":"Robert","family":"Schilz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB5|cit5","first-page":"56S","article-title":"A short-term delay of endothelin antagonist therapy results in a decreased long-term improvement in exercise capacity","volume":"136","author":"Waxman","year":"2009","journal-title":"CHEST"},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB6|cit6","first-page":"A1042","article-title":"Blinded, long-term safety and efficacy of tadalafil in treatment for pulmonary arterial hypertension","volume":"179","author":"Oudiz","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 Expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J ."},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB10|cit10","unstructured":"Tankersley MA D\u2019Albini LD Ozanich AN Whitman AJ A 36-Month survival analysis of patients beginning oral PAH monotherapy: an indication for escalation of therapy?"},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB11|cit11","article-title":"Use of parenteral prostanoids at time of death in patients with pulmonary arterial hypertension enrolled in REVEAL","volume":"140","author":"Farber","year":"2005","journal-title":"CHEST"},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB12|cit12","unstructured":"Zeribi KA Marquez L Approaches to healthcare quality regulation in Latin America and the Caribbean: regional experiences and challenges"},{"key":"10.1111\/j.1742-1241.2011.02835.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.21693\/1933-088X-9.4.204","article-title":"The structure of pulmonary hypertension health care delivery: translating ethical considerations into practice","volume":"9","author":"McGoon","year":"2011","journal-title":"Advances in Pulmonary Hypertension"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02835.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02835.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:08:24Z","timestamp":1643350104000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02835.x"}},"subtitle":["Editorial"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02835.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}